Turn Clinical Data Into Strategic Presentations
From clinical trials to commercial launch—translate complex life sciences data into presentations any stakeholder can understand.
The Pharma Presentation Problem
Complex data, diverse audiences
FDA briefing docs take months
Your medical writers and regulatory team spend weeks formatting the same data into different presentation formats.
Investor presentations are outdated immediately
Pipeline status changes, trial results come in, milestones shift—your deck is always behind.
Commercial launch reviews are chaos
Rx data, payer data, HCP engagement—pulling it all together for the brand review is a quarterly nightmare.
Board presentations require medical and business context
You need to translate clinical complexity into business impact. Every quarter. For non-scientists.
Same Data, Different Audiences
R&D Leadership
Enrollment rates, protocol deviations, site performance, milestone tracking.
Commercial Team
Rx volume, market share, payer coverage, HCP engagement metrics.
Investors & Board
Pipeline NPV, probability of success, cash runway, strategic milestones.
From Molecules to Markets
SlideStrike understands the pharma lifecycle. Clinical development metrics, regulatory milestones, commercial KPIs—all translated for your audience.
Pharma FAQs
Common questions from life sciences companies
QDoes SlideStrike understand clinical trial data?
Yes. We support clinical development KPIs including enrollment rates, site activation, protocol deviations, AE reporting timelines, and study milestone tracking.
QCan SlideStrike help with FDA advisory committee presentations?
We help structure and visualize your data for regulatory presentations. You provide the clinical data, we help present it clearly to any audience.
QIs patient data secure?
SlideStrike processes data in-memory and never stores it. For clinical trials, we recommend aggregated/anonymized data exports. HIPAA compliance is on our roadmap.
QWhat about commercial launch presentations?
We support commercial metrics: market share, Rx volume, new patient starts, total patient starts, refill rates, payer coverage, and HCP reach.
QCan I generate investor presentations for biotech?
Absolutely. Pipeline visualization, probability-weighted NPV, clinical milestones, and cash runway—presented to investor standards.